Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP -PKC-K+ ATP channel pathways. by Perimal, Enoch Kumar et al.
Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP 
-PKC-K+ ATP channel pathways. 
 
ABSTRACT 
This study investigated the antinociceptive effects of zerumbone in chemical behavioural 
models of nociception in mice. Zerumbone given through intraperitoneal route (i.p.) produced 
dose-related antinociception when assessed on acetic acid-induced abdominal writhing test in 
mice. In addition, the i.p. administration of zerumbone exhibited significant inhibition of the 
neurogenic pain induced by intraplantar (i.pl.) injection of capsaicin and bradykinin. 
Likewise, zerumbone given by i.p. route reduced the nociception produced by i.pl. injection 
of glutamate and phorbol myristate acetate (PMA). The antinociception caused by zerumbone 
in the acetic acid test was significantly attenuated by i.p. pre-treatment of mice with l-
arginine (nitric oxide precursor) and glibenclamide (ATP-sensitive K(+) channel inhibitor). 
However, the antinociception of zerumbone was enhanced by methylene blue (non-specific 
gyanylyl cyclase inhibitor). Together, these results indicate that zerumbone produces 
pronounced antinociception against chemical models of nociception in mice. It also strongly 
suggests that the l-arginine-nitric oxide-cGMP-PKC-K(+) ATP channel pathways, the 
TRPV1 and kinin B2 receptors play an important role in the zerumbone-induced 
antinociception. 
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